May 7th 2024
An analysis showed an association between patients who previously had undergone intravitreal injections and cataract surgery and a higher risk of the development of a non-clearing vitreous hemorrhage, retinal detachment, retinal tear, and glaucoma surgery.
Heading to ARVO? You’re invited to dinner COPE CE/CME. Or join virtually!
May 6 & 7, 2024
Register Now!
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
17th Annual Controversies in Modern Eye Care
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
What’s New in MGD Beyond Heating and Squeezing?
View More
The Ins and Outs of Lubricating Eye Drops
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)
View More
Community Practice Connections™: Novel Treatment Strategies in the Management of nAMD & DME - Lessons from Clinical Trial and Real-World Data
View More
Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME – Optimizing Reduction in Treatment Burden
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (COPE Credit)
View More
EyeCon 2024
September 27-28, 2024
Register Now!
Heading to AAO? You’re invited to a CME dinner. Or join virtually!
Date TBA
Register Now!
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
CMV retinitis treatment responding to changing HIV therapy
December 1st 2002Editor's Note: HIV/AIDS continues to be a major health problem, not only in the developing world, but in North America and Europe as well. Although the incidence of ocular complications of HIV/AIDS has decreased dramatically since the introduction of highly active anti-retroviral therapy (HAART), the prevalence of HIV positivity continues toincrease, particularly among heterosexual women and minorities.
Read More
Clinicians take heed with new glaucoma procedures
November 15th 2002Los Angeles-Considering the limited availability of published randomized trials, glaucoma surgeons should remain skeptical about the safety and efficacy of viscocanalostomy and deep sclerectomy with collagen wick, said Donald S. Minckler, MD.
Read More
Creation of retinochoroidal anastomosis may help those with CRVO
November 1st 2002Mexico City-Surgical treatment of central retinal vein occlusion (CRVO) by the creation of retinochoroidal anastomosis (RCA) may become an effective therapy for some patients with CRVO, according to Hugo Quiroz-Mercado, MD.
Read More
Posterior chamber PRL corrects moderate to high hyperopia
November 1st 2002Rockville Centre, NY-Implantation of a posterior chamber phakic refractive lens (PRL) (Medennium phakic refractive lens, CIBA Vision, Duluth, GA) demonstrated positive visual outcomes in the treatment of high hyperopia, according to Alexander Hatsis, MD, who presented the results of the FDA phase II trial.
Read More
Injecting botulinum toxin A in frontalis may result in ptosis
October 15th 2002New York-Eyelid ptosis following botulinum toxin A (Botox, Allergan) therapy is directly related to using frontalis injection, though other investigators have not linked the characteristic droopiness to that approach, said Michael Kane, MD.
Read More
Vitrectomy may help manage complex, refractory glaucoma
October 15th 2002The management of refractory and complex glaucoma is a challenging and often humbling undertaking. These difficult-to-treat glaucomas include neovascular, traumatic, uveitic, secondary angle closure, postsurgical, and refractory open-angle glaucoma (OAG).
Read More
PCO incidence may decline using photolysis system
October 15th 2002New York-The incidence of posterior capsule opacification (PCO) was found to be significantly lower following cataract extraction with the Nd:YAG laser (Dodick photolysis system, ARC Laser Corp.) than with conventional phaco, according to a study performed at the Manhattan Eye, Ear, and Throat Hospital (MEETH), New York.
Read More
Polishing anterior capsule may increase incidence of PCO
October 15th 2002Los Angeles-Polishing the anterior capsule after phacoemulsification and lens implantation does not appear to reduce the incidence of posterior capsular opacification (PCO). In fact, substantially more eyes that underwent this procedure after cataract surgery needed posterior capsulotomy, a startling finding reported by Kevin M. Miller, MD.
Read More
IOL technology mimics 53-year-old crystalline lens
October 15th 2002Jackson, MI-The new AcrySof Natural IOL (Model SB30AL, Alcon, Fort Worth, TX), which has a light transmission spectrum similar to that of a 53-year-old human crystalline lens, is the first of its kind that has become commercially available. It effectively filters blue light between 400 and 500 nm and preserves contrast sensitivity and color perception, according to Paul Ernest, MD.
Read More
Ophthalmic innovations abound at AAO exhibits in Orlando
October 1st 2002All eyes are focused on Orlando for this year's meeting of the American Academy of Ophthalmology (AAO), Oct. 20 to 23. More than 500 exhibitors will showcase the latest ophthalmic technology in Halls A and B (Level 2) of the Orange County Convention Center.
Read More
Sandwich technique prevents capsular bag opacification
October 1st 2002Salt Lake City-A "sandwich-like" pattern of capsular attachment of a new one-piece hydrophobic acrylic IOL (AcrySof SA30AL, Alcon, Fort Worth, TX) appears to prohibit epithelial ingrowth, according to Liliana Werner, MD, PhD.
Read More
Enhance the face with implants as well as injectables
October 1st 2002Tampa-Direct incision, the placement of autologous tissue grafts, and now the use of expanded polytetrafluoroethylene, or ePTFE, are options for improving facial subunits. While communication between the doctor and patient is important in all cases to determine which option is best, it is particularly useful with ePTFE (SoftForm) implants. The key to patient happiness is patient selection.
Read More
Commitment to R&D strengthens Allergan product pipeline
October 1st 2002Irvine, CA-When Allergan announced in January that it planned to spin off its optical medical device business into a separate company called Advanced Medical Optics (AMO), David E.I. Pyott, chairman, president, and CEO of Allergan, said the company would evolve into a specialty pharmaceutical company.
Read More
Minimal PCO, inflammation seen with single-piece acrylic IOLs
October 1st 2002Baltimore-The AcrySof single-piece acrylic IOLs (Alcon, Fort Worth, TX) provide good refractive correction, excellent stability, and a low incidence of posterior capsular opacification (PCO), said Richard A. Adler, MD.
Read More
Two-piece anterior chamber IOL offers hope for myopia
October 1st 2002New York-An anterior chamber phakic IOL for the treatment of high myopia combats the four major problems facing anterior chamber lenses, according to cataract sur-geon Charles D. Kelman, MD, who described the advantages of his invention.
Read More
Myopia cases on rise: 30-day lenses might offer alternative to LASIK
September 15th 2002Sydney, Australia-A rapid increase in the occurrence of myopia and an aging world population means 70% of the world will require vision correction by year 2020, according to a study by the Cooperative Research Centre for Eye Research and Technology.
Read More
Early results promising for two IOLs with sharp-edged optics
August 15th 2002Philadelphia-A new silicone IOL and a new hydrophobic acrylate lens are both easy and safe to implant, offering reliable refraction for patients with high myopia and high hyperopia, said Gerd U. Auffarth, MD, at the American Society of Cataract and Refractive Surgery annual meeting here.
Read More
Incorrect lens power still the most common reason for IOL explantation
August 15th 2002Philadelphia-Incorrect lens power continues to top the list as the most common reason for IOL explantation, followed by dislocation/decentration, reported Nick Mamalis, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) here.
Read More
Phakic lens holds promise for correcting high myopia, hyperopia
August 1st 2002Philadelphia-Patients with high myopia and high hyperopia seemed to have a good response to the implantation of the Phakic Refractive Lens (PRL, Medennium Inc.), according to Kenneth J. Hoffer, MD, who reported on the phase III trial for myopia and the phase II trial for hyperopia during the American Society of Cataract and Refractive Surgery meeting here.
Read More
Majority of patients satisfied with results of ICL
August 1st 2002Philadelphia-Most of the patients treated for high myopia with the Implantable Contact Lens (ICL, STAAR Surgical) were satisfied with their vision at the 2-year follow-up, said John A. Vukich, MD, who reported the interim results of the FDA clinical trial during the American Society of Cataract and Refractive Surgery annual meeting.
Read More
Researchers presented new strategies for tack-ling numerous retinal diseases that can have devastating effects on vision in a symposium entitled "New Vessels, New Medicines, New Ideas in Retina." Great progress has been made and con-tinues to be made in this subspecialty, noted Harry W. Flynn Jr., MD, organizer of the 2001 American Academy of Ophthalmology symposium.
Read More
Tarsal 'sandwich' procedure cosmetically repairs lower lid
June 15th 2002New Orleans-The tarsal "sandwich" technique facilitates cosmetic repair of lower eyelid malpositions caused by trauma or infection. The reconstruction surgery offers a cosmetically pleasing result and is among the most difficult challenges for the surgeon, according to Richard J. Hesse, MD, author of a recent report on the subject. The tarsal sandwich procedure is for pa-tients whose malpo-sitions do not respond favorably to standard methods.
Read More
Endoscopic approach to obstruction successful in Chinese patients
June 15th 2002Hong Kong-The success rate following intranasal endoscopic dacryocystorhinostomy in Chinese patients is similar to that in Caucasian patients, based on the results of a retrospective study of patients with nasolacrimal duct obstruction, according to Lawrence Lam, MD.
Read More